FILER PROFILE · CIK 0001644965

Growth Equity Opportunities Fund IV, LLC

10 filings 6 distinct issuers Active 2018-03-05 → 2025-01-21

Track Record

Total filings

1 SCHEDULE · 9 SC

Distinct issuers

60% issuer diversity

Median stake

4.99%

32,679,649 avg shares

AI briefs cached

0/10

intent-classified filings

Filed	Form	Issuer	Stake	Shares
2025-01-21	SCHEDULE	Verona Pharma plc	4.99%	32,679,649	view →
2022-11-28	SC	Addex Therapeutics Ltd.ADXN	—	—	view →
2022-01-10	SC	Addex Therapeutics Ltd.ADXN	—	—	view →
2021-04-21	SC	Affimed N.V.	—	—	view →
2020-08-03	SC	Verona Pharma plc	—	—	view →
2020-06-24	SC	AVEO PHARMACEUTICALS, INC.	—	—	view →
2019-04-17	SC	AVEO PHARMACEUTICALS INC	—	—	view →
2018-07-10	SC	AVEO PHARMACEUTICALS INC	—	—	view →
2018-03-19	SC	Cascadian Therapeutics, Inc.	—	—	view →
2018-03-05	SC	ARCA biopharma, Inc.ORKA	—	—	view →

Free. We email you when criteria match. One-click unsubscribe in every email.

Custom alerts on filer activity · full feed access · daily intelligence · API. $1,500/mo. Pilots welcome.